Free audit · No signup
Tool Sprawl Risk Audit — Clinical Trials Operations
Find out how much spreadsheet and SaaS sprawl is costing Clinical Trials Operations — and where a purpose-built internal tool pays off.
Signs of tool sprawl in Clinical Trials Operations
- Patient recruitment is the single biggest cause of trial delay; sites enroll well below plan and the sponsor cost-of-delay runs into seven-figures-per-day on Phase III studies.
- Protocol amendments are frequent, expensive, and operationally disruptive — every amendment ripples through CTMS, EDC, eConsent, and site training.
- Regulatory and quality discipline (GCP, ICH, 21 CFR Part 11, EU CTR) is non-negotiable and the audit-and-evidence workflow is sustained.
- Site activation cycles are long; the time from contract-and-budget execution to first-patient-in is the operational bottleneck nobody loves.
Source of Truth
Whether your operational data lives in one place or is scattered across tools.
More tools for Clinical Trials Operations
AI Readiness Audit
Score process clarity, data readiness, team adoption, and guardrails before investing in AI.
Sample output
67/100 → pilot with control, not full rollout
Digital Transformation Audit
Assess KPI clarity, reporting, tool alignment, ownership, and automation maturity.
Sample output
52/100 → foundation gaps in metrics and handoffs
Supplier Cost Audit
Assess supplier diversification, cost visibility, pricing competitiveness, and negotiation strength.
Sample output
65/100 → 3-5% cost reduction opportunity
Cost of Manual Work — Clinical Trials Operations
Quantify the annual cost and people-weeks lost to repetitive manual work — and the automation payback.
Build vs Buy — Clinical Trials Operations
Compare the multi-year total cost of SaaS subscriptions against a custom build — with a clear build, buy, or hybrid recommendation.
Revenue Leak — Clinical Trials Operations
See how much revenue leaks every month from a low conversion rate — and what closing the gap to your target is worth.